• 4-Ethylphenyl sulfate: Biomarker and Modulator in Renal & Ne

  2026-05-07

  4-Ethylphenyl sulfate is a microbiota-derived metabolite and uremic toxin biomarker implicated in renal dysfunction and behavioral modulation. Its elevated serum levels signal chronic kidney disease, and it is increasingly used in gut microbiota-brain interaction research. This dossier outlines its mechanistic basis, evidence, and protocol integration for laboratory workflows.

• Selective CUX2 Neuron Loss in Neuroinflammation Linked to DN

  2026-05-06

  This study reveals that DNA damage burden drives the selective loss of CUX2-expressing layer 2/3 cortical neurons in neuroinflammatory conditions, such as multiple sclerosis. By elucidating the molecular mechanisms of neuronal vulnerability and repair, it provides a new framework for understanding region- and cell type-specific neurodegeneration.

• Tigecycline: Glycylcycline Antibiotic for Multidrug Resistan

  2026-05-06

  Tigecycline’s broad-spectrum potency and unique mechanism empower researchers to tackle multidrug-resistant pathogens in advanced microbial and cellular workflows. This guide details step-wise protocols, troubleshooting tactics, and practical assay enhancements, drawing on recent resistance surveillance and validated optimization strategies.

• Cy5-UTP: Precision RNA Labeling for FISH and Expression Arra

  2026-05-05

  Cy5-UTP (Cyanine 5-UTP) enables high-sensitivity, direct fluorescent RNA labeling—ideal for in vitro transcription, FISH, and dual-color expression arrays. Its robust performance and compatibility with T7 RNA polymerase streamline probe synthesis for advanced molecular biology applications.

• Bile Acid Metabolism Subtypes Reveal CRC Immune Markers

  2026-05-05

  Feng et al. (2026) developed an integrative subtyping of colorectal cancer (CRC) based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as markers of immune dysfunction and poor prognosis. Their approach links metabolic state to tumor immune microenvironment and patient outcomes, providing new avenues for biomarker-based CRC stratification.

• Necrosulfonamide (NSA): Advanced Insights for Necroptosis Pa

  2026-05-04

  Explore how Necrosulfonamide (NSA) empowers high-precision necroptosis research by targeting MLKL translocation. This article delves beyond protocols, offering advanced scientific context, new reference-backed insights, and practical assay guidance.

• Recombinant Annexin V Enables Sensitive Detection of Apoptos

  2026-05-04

  This study details the robust bacterial expression and purification of recombinant annexin V, a key probe for detecting phosphatidylserine externalization during apoptosis. The paper's technical advances streamline apoptotic cell identification, offering reproducible, high-yield workflows that underpin both mechanistic and applied cell death research.

• Phenothiazines Promote Macrophage Antibacterial Activity via

  2026-05-03

  This study reveals that phenothiazines, including perphenazine, boost macrophage antibacterial defenses by promoting reactive oxygen species (ROS) accumulation and autophagy. These findings suggest a potential host-directed therapy approach for combating intracellular bacterial infections and antibiotic resistance.

• Streptozotocin in Diabetes Research: Protocols & Innovations

  2026-05-02

  Streptozotocin (STZ) is the gold-standard tool for experimental diabetes mellitus induction, enabling precise modeling of β-cell apoptosis and neuroimmune complications. This guide details optimized workflows, troubleshooting strategies, and the translational impact of cutting-edge research leveraging STZ from APExBIO.

• Midecamycin: Applied Protocols for Gram-Positive Inhibition

  2026-05-02

  Midecamycin, a 16-membered acetoxy-substituted macrolide antibiotic, delivers precise and robust inhibition of Gram-positive bacteria by targeting bacterial protein synthesis. This article translates current research and quantitative protocols into practical workflows, troubleshooting strategies, and comparative advantages for microbiology laboratories seeking advanced antibacterial control.

• WZ4003: Precision NUAK1/2 Inhibitor Workflows in Cancer & Ta

  2026-05-01

  WZ4003 is a best-in-class NUAK1/2 inhibitor with nanomolar potency, enabling researchers to dissect cell migration, proliferation, and tau phosphorylation with high specificity. This article translates recent landmark findings and validated experimental workflows into actionable guidance for optimizing cancer and neurodegeneration assays using WZ4003 from APExBIO.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-04-30

  Recent research reveals that moxidectin, beyond its veterinary antiparasitic role, dramatically enhances polyene antifungal action against Candida albicans by upregulating ergosterol biosynthesis. This article translates these findings into actionable, experiment-ready workflows with troubleshooting insight, making APExBIO's high-purity moxidectin an indispensable tool for modern antifungal assay development.

• TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M

  2026-04-30

  Liao et al. (2024) identify TANK-binding kinase 1 (TBK1) as a pivotal mediator of painful diabetic neuropathy (PDN) through its regulation of microglial pyroptosis. The study demonstrates that both genetic and pharmacological TBK1 inhibition reduce neuroinflammation and pain, offering a mechanistic foundation for targeting TBK1 in PDN therapy.

• Hydrocortisone in Bench Research: Protocols, Models, and Tro

  2026-04-29

  Hydrocortisone stands as the gold-standard glucocorticoid hormone for dissecting stress, inflammation, and neuroprotection in both cellular and animal research models. This guide distills best practices for experimental workflows, data-driven troubleshooting, and integrating hydrocortisone’s unique properties into state-of-the-art biomedical studies.

• HyperFluor 488 Goat Anti-Mouse IgG: Amplified Detection in V

  2026-04-29

  The HyperFluor 488 Goat Anti-Mouse IgG (H+L) Antibody delivers unmatched sensitivity for detecting subtle endothelial changes in radiation injury models. This fluorescently labeled secondary antibody, supplied by APExBIO, enables robust signal amplification and reproducibility across immunofluorescence, flow cytometry, and western blotting workflows.

436 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page